CNBC Squawk On The Street July 12, 2024
Something positive, right, with that rising case count hitting new records, it seems virtually every day, and deaths also starting to move up in knows hardhit states as well with hospitalizations thats certainly been a focus for Market Participants as you guys well know Scott Gottlieb who we follow closely tweeting about the remdesivir news, very encouraged but needs to be confirmed in a prospective trial, appears to be a receipt peck testify analysis of the face three data suggesting a survival benefit in severe Covid Patients. We have made the point many times it is only good news on remdesi...
Source: archive.org
